SCHEMBL19720235

SCHEMBL19720235

CC(=O)Nc1cccc(COS(C)(=O)=O)c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
CYP1A2 P05177 1/20 0.53
RAB9A P51151 2/20 0.52
LMNA P02545 1/20 0.50
SIRT2 Q8IXJ6 1/20 0.50
SIRT3 Q9NTG7 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
POLB P06746 1/20 0.49
NR4A1 P22736 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
TSHR P16473 1/20 0.48
MAOB P27338 1/20 0.47
CYP19A1 P11511 1/20 0.47
NPC1 O15118 1/20 0.47
NLRP3 Q96P20 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4201979 0.83 MAPK1 (0.56) ALDH1A1CYP1A2RAB9ALMNAHSD17B10
SCHEMBL28742452 0.83 ALDH1A1 (0.61) ALDH1A1CYP1A2RAB9ASIRT2SIRT3
SCHEMBL1025076 0.82 SIRT2 (0.48) SIRT2
SCHEMBL16230241 0.81 APP (0.41) ALDH1A1RAB9ASIRT2SIRT3HSD17B10
SCHEMBL791661 0.81 ALDH1A1 (0.59) ALDH1A1CYP1A2RAB9ASIRT2SIRT3
SCHEMBL26964 0.80 NR3C1 (0.55) ALDH1A1CYP1A2RAB9ALMNAPOLB
SCHEMBL9815416 0.80 RAB9A (0.63) ALDH1A1CYP1A2RAB9ASIRT2SIRT3
SCHEMBL8063113 0.79 CA2 (0.45) ALDH1A1CYP1A2LMNATSHRCYP19A1
SCHEMBL12136904 0.78 NFATC1 (0.58) ALDH1A1CYP1A2RAB9ANPSR1POLB
SCHEMBL7666457 0.76 ALDH1A1 (0.59) ALDH1A1CYP1A2RAB9ANPSR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110433162-A It can be used as the dihydronaphthridine and related compound of the kinase inhibitor for treating proliferative disease DECIPHERA PHARMACEUTICALS LLC 2019-11-12 CN disclosed
CN-110403938-A It can be used as the dihydronaphthridine and related compound of the kinase inhibitor for treating proliferative disease DECIPHERA PHARMACEUTICALS LLC 2019-11-05 CN disclosed
CN-104902895-B Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases 德西费拉制药有限责任公司 2019-03-29 CN disclosed
EP-2858646-B1 DIHYDRONAPHTHYRIDINES AND RELATED COMPOUNDS USEFUL AS KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES DECIPHERA PHARMACEUTICALS LLC (US) 2017-12-20 EP disclosed